MedTrace Logo

PEEP Mask for Tracheobronchomalacia-Induced Cough

NCT04169282 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2023-09-28

Study results available
· View outcomes & findings →

Summary

This study aims to determine if an expiratory resistance device that delivers non-invasive positive expiratory pressure (nPEP) will reduce or stop coughing, reduce airway resistance and improve quality of life in patients with tracheobronchomalacia (TBM) who are not candidates for tracheal stenting.

Conditions

  • Tracheobronchomalacia

Interventions

DEVICE

nPEP (non-invasive positive expiratory pressure) mask

Positive end expiratory pressure (PEEP) mask

Sponsors & Collaborators

Principal Investigators

  • Loretta G Que, MD · Duke University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-30
Primary Completion
2022-08-15
Completion
2022-08-15
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04169282 on ClinicalTrials.gov